Compare $HAE vs $LNTH | Chartloom

Compare

$HAE vs $LNTH

Haemonetics Corp · Lantheus Holdings Inc

HAE

Haemonetics Corp

LNTH

Lantheus Holdings Inc

Compare $HAE vs $LNTH

Comparing Haemonetics Corp and Lantheus Holdings Inc

HAEHaemonetics Corp

LNTHLantheus Holdings Inc

HAEHaemonetics Corp

Market cap

$5.39B

P/E (TTM)

56.34x

Forward P/E (NTM)

21.33x

Forward P/S (NTM)

3.72x

Rev growth (TTM)

0.4%

YTD performance

48.4%

52W performance

132.8%

FCF yield

4.5%

LNTHLantheus Holdings Inc

Market cap

$6.52B

P/E (TTM)

24.56x

Forward P/E (NTM)

17.43x

Forward P/S (NTM)

4.16x

Rev growth (TTM)

2.3%

YTD performance

48.9%

52W performance

87.0%

FCF yield

5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HAE

LNTH

Detailed metrics comparison

HAE

Haemonetics Corp

LNTH

Lantheus Holdings Inc

Market Cap

HAE$5.39B

LNTH$6.52B

Enterprise Value

HAE$6.35B

LNTH$6.50B

Price

HAE$118.69

LNTH$100.15

P/E Ratio

HAE56.34x

LNTH24.56x

P/S Ratio

HAE3.99x

LNTH4.19x

EV/Sales

HAE4.69x

LNTH4.18x

EV/EBITDA

HAE17.94x

LNTH15.80x

P/B Ratio

HAE5.69x

LNTH4.98x

P/FCF Ratio

HAE22.00x

LNTH16.81x

EV/FCF

HAE25.88x

LNTH16.76x

PEG Ratio

HAEN/A

LNTH2.43x

Forward P/E (NTM)

HAE21.33x

LNTH17.43x

Forward P/S (NTM)

HAE3.72x

LNTH4.16x

Revenue (TTM)

HAE$1.35B

LNTH$1.56B

Revenue Growth (YoY)

HAE0.4%

LNTH2.3%

Forward Rev Growth

HAE5.2%

LNTH11.8%

Gross Margin (TTM)

HAE59.1%

LNTH61.0%

Operating Margin (TTM)

HAE11.9%

LNTH23.3%

EBITDA Margin (TTM)

HAE26.2%

LNTH25.9%

Net Margin (TTM)

HAE7.1%

LNTH17.7%

FCF Margin (TTM)

HAE18.1%

LNTH24.9%

Net Income (TTM)

HAE$96M

LNTH$275M

FCF (TTM)

HAE$245M

LNTH$388M

EPS (TTM)

HAE$2.11

LNTH$4.08

ROE (TTM)

HAE11.3%

LNTH23.3%

ROA (TTM)

HAE4.0%

LNTH11.9%

ROIC (TTM)

HAE4.7%

LNTH15.7%

Cash

HAE$223M

LNTH$593M

Debt

HAE$1.17B

LNTH$571M

Net Cash/Debt

HAE$-951M

LNTH$22M

Current Ratio (TTM)

HAE3.08x

LNTH3.06x

Quick Ratio (TTM)

HAE1.67x

LNTH2.89x

Debt/Equity (TTM)

HAE1.40x

LNTH0.44x

Debt/Assets (TTM)

HAE0.0%

LNTH0.0%

Interest Coverage (TTM)

HAEN/A

LNTHN/A

Net Debt/EBITDA (TTM)

HAE0.00x

LNTH0.00x

Beta

HAE0.62

LNTH0.04

52W Performance

HAE132.8%

LNTH87.0%

YTD Performance

HAE48.4%

LNTH48.9%

% from 52W High

HAE-2.1%

LNTH-10.5%

% from 52W Low

HAE146.4%

LNTH99.7%

Asset Turnover (TTM)

HAE0.56x

LNTH0.67x

FCF Yield (TTM)

HAE4.5%

LNTH5.9%

Earnings Yield (TTM)

HAE1.8%

LNTH4.2%

Dividend Yield (TTM)

HAEN/A

LNTHN/A

Rule of 40

HAE18.6

LNTH27.3

EV/GP/RG

HAE1.08

LNTH11.23

Ticker research

View HAE research View LNTH research

Metric	HAE Haemonetics Corp	LNTH Lantheus Holdings Inc
Market & Valuation
Market Cap	$5.39B	$6.52B
Enterprise Value	$6.35B	$6.50B
Price	$118.69	$100.15
P/E Ratio	56.34x	24.56x
P/S Ratio	3.99x	4.19x
EV/Sales	4.69x	4.18x
EV/EBITDA	17.94x	15.80x
P/B Ratio	5.69x	4.98x
P/FCF Ratio	22.00x	16.81x
EV/FCF	25.88x	16.76x
PEG Ratio	N/A	2.43x
Forward P/E (NTM)	21.33x	17.43x
Forward P/S (NTM)	3.72x	4.16x
Revenue & Growth
Revenue (TTM)	$1.35B	$1.56B
Revenue Growth (YoY)	0.4%	2.3%
Forward Rev Growth	5.2%	11.8%
Profitability
Gross Margin (TTM)	59.1%	61.0%
Operating Margin (TTM)	11.9%	23.3%
EBITDA Margin (TTM)	26.2%	25.9%
Net Margin (TTM)	7.1%	17.7%
FCF Margin (TTM)	18.1%	24.9%
Net Income (TTM)	$96M	$275M
FCF (TTM)	$245M	$388M
EPS (TTM)	$2.11	$4.08
ROE (TTM)	11.3%	23.3%
ROA (TTM)	4.0%	11.9%
ROIC (TTM)	4.7%	15.7%
Financial Health
Cash	$223M	$593M
Debt	$1.17B	$571M
Net Cash/Debt	$-951M	$22M
Current Ratio (TTM)	3.08x	3.06x
Quick Ratio (TTM)	1.67x	2.89x
Debt/Equity (TTM)	1.40x	0.44x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.04
52W Performance	132.8%	87.0%
YTD Performance	48.4%	48.9%
% from 52W High	-2.1%	-10.5%
% from 52W Low	146.4%	99.7%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.67x
FCF Yield (TTM)	4.5%	5.9%
Earnings Yield (TTM)	1.8%	4.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.6	27.3
EV/GP/RG	1.08	11.23
Ticker research	View HAE research	View LNTH research

Valuation

P/E Ratio

LNTH

24.56x

HAE

56.34x

P/S Ratio

HAE

3.99x

LNTH

4.19x

EV/FCF

LNTH

16.76x

HAE

25.88x

Growth & revenue

Revenue Growth TTM

LNTH

2.3%

HAE

0.4%

Forward Revenue Growth

LNTH

11.8%

HAE

5.2%

Profitability & performance

Gross Margin

LNTH

61.0%

HAE

59.1%

ROE

LNTH

23.3%

HAE

11.3%

FCF Yield %

LNTH

5.9%

HAE

4.5%

52-Week Performance

HAE

132.8%

LNTH

87.0%

Detailed metrics comparison

HAE

Haemonetics Corp

LNTH

Lantheus Holdings Inc

Market Cap

HAE$5.39B

LNTH$6.52B

Enterprise Value

HAE$6.35B

LNTH$6.50B

Price

HAE$118.69

LNTH$100.15

P/E Ratio

HAE56.34x

LNTH24.56x

P/S Ratio

HAE3.99x

LNTH4.19x

EV/Sales

HAE4.69x

LNTH4.18x

EV/EBITDA

HAE17.94x

LNTH15.80x

P/B Ratio

HAE5.69x

LNTH4.98x

P/FCF Ratio

HAE22.00x

LNTH16.81x

EV/FCF

HAE25.88x

LNTH16.76x

PEG Ratio

HAEN/A

LNTH2.43x

Forward P/E (NTM)

HAE21.33x

LNTH17.43x

Forward P/S (NTM)

HAE3.72x

LNTH4.16x

Revenue (TTM)

HAE$1.35B

LNTH$1.56B

Revenue Growth (YoY)

HAE0.4%

LNTH2.3%

Forward Rev Growth

HAE5.2%

LNTH11.8%

Gross Margin (TTM)

HAE59.1%

LNTH61.0%

Operating Margin (TTM)

HAE11.9%

LNTH23.3%

EBITDA Margin (TTM)

HAE26.2%

LNTH25.9%

Net Margin (TTM)

HAE7.1%

LNTH17.7%

FCF Margin (TTM)

HAE18.1%

LNTH24.9%

Net Income (TTM)

HAE$96M

LNTH$275M

FCF (TTM)

HAE$245M

LNTH$388M

EPS (TTM)

HAE$2.11

LNTH$4.08

ROE (TTM)

HAE11.3%

LNTH23.3%

ROA (TTM)

HAE4.0%

LNTH11.9%

ROIC (TTM)

HAE4.7%

LNTH15.7%

Cash

HAE$223M

LNTH$593M

Debt

HAE$1.17B

LNTH$571M

Net Cash/Debt

HAE$-951M

LNTH$22M

Current Ratio (TTM)

HAE3.08x

LNTH3.06x

Quick Ratio (TTM)

HAE1.67x

LNTH2.89x

Debt/Equity (TTM)

HAE1.40x

LNTH0.44x

Debt/Assets (TTM)

HAE0.0%

LNTH0.0%

Interest Coverage (TTM)

HAEN/A

LNTHN/A

Net Debt/EBITDA (TTM)

HAE0.00x

LNTH0.00x

Beta

HAE0.62

LNTH0.04

52W Performance

HAE132.8%

LNTH87.0%

YTD Performance

HAE48.4%

LNTH48.9%

% from 52W High

HAE-2.1%

LNTH-10.5%

% from 52W Low

HAE146.4%

LNTH99.7%

Asset Turnover (TTM)

HAE0.56x

LNTH0.67x

FCF Yield (TTM)

HAE4.5%

LNTH5.9%

Earnings Yield (TTM)

HAE1.8%

LNTH4.2%

Dividend Yield (TTM)

HAEN/A

LNTHN/A

Rule of 40

HAE18.6

LNTH27.3

EV/GP/RG

HAE1.08

LNTH11.23

Ticker research

View HAE research View LNTH research

Metric	HAE Haemonetics Corp	LNTH Lantheus Holdings Inc
Market & Valuation
Market Cap	$5.39B	$6.52B
Enterprise Value	$6.35B	$6.50B
Price	$118.69	$100.15
P/E Ratio	56.34x	24.56x
P/S Ratio	3.99x	4.19x
EV/Sales	4.69x	4.18x
EV/EBITDA	17.94x	15.80x
P/B Ratio	5.69x	4.98x
P/FCF Ratio	22.00x	16.81x
EV/FCF	25.88x	16.76x
PEG Ratio	N/A	2.43x
Forward P/E (NTM)	21.33x	17.43x
Forward P/S (NTM)	3.72x	4.16x
Revenue & Growth
Revenue (TTM)	$1.35B	$1.56B
Revenue Growth (YoY)	0.4%	2.3%
Forward Rev Growth	5.2%	11.8%
Profitability
Gross Margin (TTM)	59.1%	61.0%
Operating Margin (TTM)	11.9%	23.3%
EBITDA Margin (TTM)	26.2%	25.9%
Net Margin (TTM)	7.1%	17.7%
FCF Margin (TTM)	18.1%	24.9%
Net Income (TTM)	$96M	$275M
FCF (TTM)	$245M	$388M
EPS (TTM)	$2.11	$4.08
ROE (TTM)	11.3%	23.3%
ROA (TTM)	4.0%	11.9%
ROIC (TTM)	4.7%	15.7%
Financial Health
Cash	$223M	$593M
Debt	$1.17B	$571M
Net Cash/Debt	$-951M	$22M
Current Ratio (TTM)	3.08x	3.06x
Quick Ratio (TTM)	1.67x	2.89x
Debt/Equity (TTM)	1.40x	0.44x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	0.04
52W Performance	132.8%	87.0%
YTD Performance	48.4%	48.9%
% from 52W High	-2.1%	-10.5%
% from 52W Low	146.4%	99.7%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.67x
FCF Yield (TTM)	4.5%	5.9%
Earnings Yield (TTM)	1.8%	4.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.6	27.3
EV/GP/RG	1.08	11.23
Ticker research	View HAE research	View LNTH research